Redeye reiterates its Base Case after reviewing Bambuser’s Q2 report. The financials were largely in line with expectations, and we only make minor forecast adjustments. The operational outlook continues to be very exciting – gaining at least one transformative enterprise account, among other things.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/